Literature DB >> 28250252

Association of IL10, IL4, IFNG, and CTLA4 Gene Polymorphisms with Efavirenz Hypersensitivity Reaction in Patients Infected with Human Immunodeficiency Virus.

Raphael de Oliveira Rodrigues1, Silvia Helena Barem Rabenhorst2, Paulo Germano de Carvalho1,3, Greyce Luri Sasahara1, Luciana Mabel Ferreira Vasconcelos1, Érico Antônio Gomes de Arruda4, Silvia Fernandes Ribeiro da Silva3,5, Ilana Farias Ribeiro5, Aparecida Tiemi Nagao-Dias1.   

Abstract

We evaluated interleukin-10 (IL10) -592 C/A, IL4-589 C/T, interferon gamma (IFNG)+874 A/T, cytotoxic T-lymphocyte-associated antigen 4 (CTLA4)+49 A/G gene polymorphisms associated with efavirenz hypersensitivity reaction. A total of 63 human immunodeficiency virus-positive patients under treatment at a public hospital were included in the study, of whom 21 presented with efavirenz hypersensitivity. Patients who presented with efavirenz hypersensitivity reaction showed a higher frequency of the IL10 -592A allele than the controls (p=0.028). The allele A was associated with increased risk of efavirenz hypersensitivity (odds ratio=2.40). In case of IL4, a significant difference in the frequency of the IL4 -589 (C/T) polymorphism was not observed between patients and controls. A significant inverse correlation was observed when comparing the CTLA4+49A/G and IL4 -589 C/T polymorphisms (r=-0.650, p=0.001); that is, the CTLA4 +49GG genotype, involved with the lowest capacity of inhibition, was inversely correlated IL4-589TT genotype, which induces high production of IL-4. With respect to the CTLA4+49A/G and IFNG+874T/A gene polymorphisms, significant differences in allele and genotype frequencies were not observed between the groups. Therefore, our data suggest that polymorphisms in regulatory regions of cytokine genes could modulate an individual's susceptibility to efavirenz hypersensitivity reaction.

Entities:  

Keywords:  HIV/AIDS; efavirenz; hypersensitivity; pharmacogenetics and pharmacogenomics

Mesh:

Substances:

Year:  2017        PMID: 28250252     DOI: 10.7883/yoken.JJID.2016.075

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  4 in total

Review 1.  Drug hypersensitivity in HIV infection.

Authors:  Jonny Peter; Phuti Choshi; Rannakoe J Lehloenya
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-08

Review 2.  Mechanistic insights into antiretroviral drug-induced liver injury.

Authors:  Jamie N Pillaye; Mohlopheni J Marakalala; Nonhlanhla Khumalo; Wendy Spearman; Hlumani Ndlovu
Journal:  Pharmacol Res Perspect       Date:  2020-08

Review 3.  The Roles of Immunoregulatory Networks in Severe Drug Hypersensitivity.

Authors:  Yun-Shiuan Olivia Hsu; Kun-Lin Lu; Yun Fu; Chuang-Wei Wang; Chun-Wei Lu; Yu-Fen Lin; Wen-Cheng Chang; Kun-Yun Yeh; Shuen-Iu Hung; Wen-Hung Chung; Chun-Bing Chen
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

4.  Association of CTLA-4 and IL-4 polymorphisms in viral induced liver cancer.

Authors:  Maria Shabbir; Yasmin Badshah; Khushbukhat Khan; Janeen H Trembley; Areeb Rizwan; Fatima Faraz; Syeda Alveena Shah; Mahrukh Farooqi; Naeem Mahmood Ashraf; Tayyaba Afsar; Ali Almajwal; Nawaf W Alruwaili; Suhail Razak
Journal:  BMC Cancer       Date:  2022-05-07       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.